- Home
- NVO vs ANET Comparison
NVO vs ANET Comparison
Compare NVO & ANET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | ANET |
|---|---|---|
| Founded | 1923 | 2004 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.6B | 173.1B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NVO | ANET |
|---|---|---|
| Price | $38.49 | $134.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | $51.00 | ★ $173.80 |
| AVG Volume (30 Days) | ★ 24.8M | 7.7M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | N/A | ★ 23.32 |
| EPS | N/A | ★ 2.75 |
| Revenue | N/A | ★ $9,005,700,000.00 |
| Revenue This Year | N/A | $28.79 |
| Revenue Next Year | $4.39 | $21.10 |
| P/E Ratio | ★ $13.60 | $45.48 |
| Revenue Growth | N/A | ★ 28.60 |
| 52 Week Low | $35.85 | $59.43 |
| 52 Week High | $89.03 | $164.94 |
Technical Indicators
Market Signals| Indicator | NVO | ANET |
|---|---|---|
| Relative Strength Index (RSI) | 30.27 | 50.48 |
| Support Level | N/A | $126.46 |
| Resistance Level | $50.30 | $139.93 |
| Average True Range (ATR) | 0.95 | 5.66 |
| MACD | -0.68 | -0.81 |
| Stochastic Oscillator | 18.53 | 45.81 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About ANET Arista Networks Inc.
Arista Networks is a networking equipment provider that mainly sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three-quarters of its sales from North America.